017810 — Pulmuone Corporate Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Market Cap
KR₩402bn
Enterprise Value
KR₩2tn
Revenue
KR₩3tn

Annual income statement for Pulmuone Corporate, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,518,896	2,838,304	2,993,468	3,213,697	3,380,189
Cost of Revenue
Gross Profit	656,235	700,419	759,041	814,475	831,625
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,492,007	2,813,313	2,940,415	3,130,788	3,290,311
Operating Profit	26,890	24,991	53,053	82,909	89,878
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13,509	-18,413	14,312	40,970	30,807
Provision for Income Taxes
Net Income After Taxes	304	-36,967	13,358	34,387	15,160
Minority Interest
Net Income Before Extraordinary Items
Net Income	13,357	-18,602	19,516	35,403	18,095
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	5,326	-29,957	9,365	25,035	3,107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	304	-803	526	718	107
Dividends per Share